Biomarin Pharmaceutical Inc
BMRN
$54.12-2.29%
Delayed · as of Oct 13, 2026, 2:00 PM ET
Mkt cap
$10.63B
EV/Sales
3.08
P/E ratio
N/A
FY2025 Revenue
$3.22B
EPS (TTM)
$0.38
Gross Margin (FY2025)
77.73%
Profit Margin (FY2025)
10.83%
Beta
N/A
Div yield
N/A
Sector
Healthcare
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Latest reported BMRN revenue for 2025-12-31 was $3.22B. Net income was $348.9M. Revenue was up 12.9% from 2024-12-31 to 2025-12-31. BMRN currently screens at market cap $10.63B.
Use this BMRN research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full BMRN income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company in the Healthcare sector.
Latest cached Biomarin Pharmaceutical Inc (BMRN) revenue for Dec 31, 2025 was $3.22B. Net income was $348.9M. Statements: https://lician.com/financials/bmrn
Biomarin Pharmaceutical Inc (BMRN) market capitalization is $10.63B on the latest cached snapshot.
Biomarin Pharmaceutical Inc (BMRN) cached previous close $55.39; day range $54.12 – $55.30; volume 1,104,696. Session quote: https://lician.com/quote/bmrn
Biomarin Pharmaceutical Inc (BMRN) latest cached earnings event is "BMRN earnings" on Aug 6, 2026. Earnings calendar: https://lician.com/earnings
The latest cached BMRN filing is 8-K · Oct 6, 2026. Filings: https://lician.com/sec/bmrn